DAPTOMYCIN Labatec subst sèche 350 mg 5 pce
7680666510032
CH-66651
J01XX09
08.01.9.
Active substances:
1 / 3
google
Details
- GTIN
- 7680666510032
- Pharmacode
- -
- Product number
- 6665101
- CPT
- -
- Packaging group
- 5
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: daptomycinum 350 mg, natrii hydroxidum, pro vitro corresp. natrium 3.38 mg.
Articles (1)
Daptomycin Labatec 350 mg, poudre pour solution injectable/pour perfusion
Puder
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
daptomycinum
|
350.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
3.38 MG | Substance | HBESI |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 66651
- Drug name
- Daptomycin Labatec, poudre pour solution injectable/pour perfusion
- Galenic form
- PULPA
- ATC Code
- J01XX09
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/01/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 08.01.9.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DAPTOMYCIN Labatec subst sèche 350 mg 5 pce
- Description (DE)
- DAPTOMYCIN Labatec Trockensub 350 mg 5 Stk
- Market launch
- 23/01/2019
- Narcotic (BTM)
- No
Available generics
Daptomycin Accord, Pulver zur Herstellung einer Infusions-/Injektionslösung
GTIN:
7680672730011
CHF 92.00
Daptomycin Accord, Pulver zur Herstellung einer Infusions-/Injektionslösung
GTIN:
7680672730028
CHF 124.40